Boutron, Isabelle

Increasing value and reducing waste in biomedical research: who's listening?

Moher, D., Glasziou, P., Chalmers, I., Nasser, M., Bossuyt, P. M. M., Korevaar, D. A., Graham, I. D., Ravaud, P., & Boutron, I. (2016) · The Lancet

Health and Medical Research ImpactsHealthcare cost, quality, practices

Cited by 462

SPIRIT 2025 statement: updated guideline for protocols of randomised trials

Chan, A.-W., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 460

Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews

Jørgensen, L., Paludan-Müller, A. S., Laursen, D. R. T., Savović, J., Boutron, I., Sterne, J. A. C., Higgins, J. P. T., & Hróbjartsson, A. (2016) · Systematic Reviews

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 396

Reporting methods of blinding in randomized trials assessing nonpharmacological treatments

Boutron, I., Guittet, L., Estellat, C., Moher, D., Hróbjartsson, A., & Ravaud, P. (2007) · PLoS Medicine

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 389

Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial

Boutron, I., Altman, D. G., Hopewell, S., Vera-Badillo, F., Tannock, I., & Ravaud, P. (2014) · Journal of Clinical Oncology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 368

Systematic review adherence to methodological or reporting quality

Pussegoda, K., Turner, L., Garritty, C., Mayhew, A., Skidmore, B., Stevens, A., Boutron, I., Sarkis-Onofre, R., Bjerre, L. M., Hróbjartsson, A., et al. (2017) · Systematic Reviews

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 322

Efficacy and safety of COVID-19 vaccines

Graña, C., Ghosn, L., Evrenoglou, T., Jarde, A., Minozzi, S., Bergman, H., Buckley, B. S., Probyn, K., Villanueva, G., Henschke, N., et al. (2022) · Cochrane Database of Systematic Reviews

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 310

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus

BOUTRON, I., MOHER, D., TUGWELL, P., GIRAUDEAU, B., POIRAUDEAU, S., NIZARD, R., & RAVAUD, P. (2005) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 308

Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study

Dechartres, A., Boutron, I., Trinquart, L., Charles, P., & Ravaud, P. (2011) · Annals of Internal Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 307

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study

Moustgaard, H., Clayton, G. L., Jones, H. E., Boutron, I., Jørgensen, L., Laursen, D. R. T., Olsen, M. F., Paludan-Müller, A., Ravaud, P., Savović, J., et al. (2020) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 300

Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials

Boutron, I., Tubach, F., Giraudeau, B., & Ravaud, P. (2004) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 300

Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study

Yavchitz, A., Boutron, I., Bafeta, A., Marroun, I., Charles, P., Mantz, J., & Ravaud, P. (2012) · PLoS Medicine

Academic Publishing and Open AccessPharmaceutical industry and healthcare

Cited by 293

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

Pitrou, I., Boutron, I., Ahmad, N., & Ravaud, P. (2009) · Archives of Internal Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 287

Misrepresentation and distortion of research in biomedical literature

Boutron, I., & Ravaud, P. (2018) · Proceedings of the National Academy of Sciences

Academic Publishing and Open AccessAcademic integrity and plagiarism

Cited by 273

Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals

Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I., & Ravaud, P. (2013) · PLoS Medicine

Pharmaceutical industry and healthcareAcademic Publishing and Open Access

Cited by 269

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

Flemyng, E., Moore, T. H., Boutron, I., Higgins, J. P., Hróbjartsson, A., Nejstgaard, C. H., & Dwan, K. (2023) · BMJ Evidence-Based Medicine

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 264

Considering bias and conflicts of interest among the included studies

Boutron, I., Page, M. J., Higgins, J. P., Altman, D. G., Lundh, A., Hróbjartsson, A., & on behalf of the Cochrane Bias Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 258

Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis

Hopewell, S., Ravaud, P., Baron, G., & Boutron, I. (2012) · BMJ

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 235

Association Between Analytic Strategy and Estimates of Treatment Outcomes in Meta-analyses

Dechartres, A., Altman, D. G., Trinquart, L., Boutron, I., & Ravaud, P. (2014) · JAMA

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 233

A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity

Yavchitz, A., Ravaud, P., Altman, D. G., Moher, D., Hrobjartsson, A., Lasserson, T., & Boutron, I. (2016) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 224

Impact of interventions to improve the quality of peer review of biomedical journals: a systematic review and meta-analysis

Bruce, R., Chauvin, A., Trinquart, L., Ravaud, P., & Boutron, I. (2016) · BMC Medicine

Publishing and Scholarly CommunicationAcademic Publishing and Open Access

Cited by 218

Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T., Mulrow, C. D., Shamseer, L., & Moher, D. (2020) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 211

Taking healthcare interventions from trial to practice

Glasziou, P., Chalmers, I., Altman, D. G., Bastian, H., Boutron, I., Brice, A., Jamtvedt, G., Farmer, A., Ghersi, D., Groves, T., et al. (2010) · BMJ

Meta-analysis and systematic reviewsHealth Policy Implementation Science

Cited by 209

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 205